Image

Global Diagnostic Tests Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Mar 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Diagnostic Tests Market, By Type (Glucose Test, Infectious Diseases Test, Cytology Test, CBC Test, Blood Culture Test, Syphilis Test, Urea Test, C-Reactive Protein Test, Antigen Test, HBA1C Test, Pregnancy Test, Lipid Profile Test, Electrolytes Test, Liver Function Test, Stool Helicobacter Pylori Test, Calcium Test, Crossmatch Test, Thyroid Function Test, Stool Microscopy Test, Urine Microscopy Test, Unit Packed RBCS Test, ESR Test and Others Test), Solution (Services and Products), Technology (Immunoassay-Based, PCR-Based, Next Gene Sequencing, Spectroscopy-Based, Chromatography-Based, Microfluidics, Substrate Technology and Others), Mode of Testing (Prescription Based Testing, OTC Testing), Approach (Molecular Diagnostic Instrument, In-Vitro Diagnostic Instrument & Point of Care Testing Instrument), Sample Type (Urine, Saliva, Blood, Hair, Sweat, and Others), Application (Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology, Gynecology, Odontology, and Others),Testing Type (Biochemistry, Hematology, Microbiology, Histopathology and Others), Age (Pediatric, Adult & Geriatric), End User (Hospitals, Diagnostic Center, Research Labs and Institutes, Research Institute, Homecare, Blood Banks, Specialty Clinics, Ambulatory Surgical Centers (ASCs), Others), Distribution Channel (Direct Tenders, Retail Sales, Online Sales) – Industry Trends and Forecast to 2029.

Diagnostic Tests Market

Global Diagnostic Tests Market Analysis and Size

In recent years, the need for diagnostic tests have rapidly increased owing to the emergence of various diseases and infections. The rise in the investment for diagnostic tests is escalating the growth of diagnostic tests market.

  • Global diagnostic tests market was valued at USD 162,456.67 million in 2021 and is expected to reach USD 339,892.97 million by 2029, registering a CAGR of 9.00% during the forecast period of 2022-2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Global Diagnostic Tests Market Definition

Diagnostic tests refer to the type of medical tests that are performed to aid in the detection or diagnosis of any disease. These tests have a crucial role in the control, surveillance and prevention of any disease. These type of tests in enhancing patient care, consumer safety, and reducing healthcare spending.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Type (Glucose Test, Infectious Diseases Test, Cytology Test, CBC Test, Blood Culture Test, Syphilis Test, Urea Test, C-Reactive Protein Test, Antigen Test, HBA1C Test, Pregnancy Test, Lipid Profile Test, Electrolytes Test, Liver Function Test, Stool Helicobacter Pylori Test, Calcium Test, Crossmatch Test, Thyroid Function Test, Stool Microscopy Test, Urine Microscopy Test, Unit Packed RBCS Test, ESR Test and Others Test), Solution (Services and Products), Technology (Immunoassay-Based, PCR-Based, Next Gene Sequencing, Spectroscopy-Based, Chromatography-Based, Microfluidics, Substrate Technology and Others), Mode of Testing (Prescription Based Testing, OTC Testing), Approach (Molecular Diagnostic Instrument, In-Vitro Diagnostic Instrument & Point of Care Testing Instrument), Sample Type (Urine, Saliva, Blood, Hair, Sweat, and Others), Application (Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology, Gynecology, Odontology, and Others),Testing Type (Biochemistry, Hematology, Microbiology, Histopathology and Others), Age (Pediatric, Adult & Geriatric), End User (Hospitals, Diagnostic Center, Research Labs and Institutes, Research Institute, Homecare, Blood Banks, Specialty Clinics, Ambulatory Surgical Centers (ASCs), Others), Distribution Channel (Direct Tenders, Retail Sales, Online Sales)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

H-Hoffman La-Rcohe Ltd. (Switzerland), ABBOTT (US), Danaher (US), BD (US), Thermo Fisher Scientific Inc. (US), ACON Laboratories Inc. (US), Hemosure, Inc. (US), MicroGen Diagnostics (US), QIAGEN (Germany), Grifols, S.A (Spain), BODITECH MED INC. (South Korea), Chembio Diagnostic Systems, Inc. (US), Nanoentek (South Korea), DiaSorin S.p.A. (Italy), Bio-Rad Laboratories, Inc. (US), BIOMEDOMICS INC (US),  EKF Diagnostics Holdings plc (UK), Siemens Healthcare GmbH (Germany), PerkinElmer Inc. (US), bioMérieux SA (France), ARKRAY USA, Inc. (US), Biohit Oyj (Finland), Germaine Laboratories, Inc. (US), Quidel Corporation (US), Illumina, Inc. (US), Lamdagen Corporation (US), LifeSign LLC. (US), Medixbiochemica (Finaland), Nova Biomedical (US), Ortho Clinical Diagnostics (US), Sannuo Biosensing Co., Ltd. (US), STRECK (US), Sysmex Corporation (Japan), among others

Market Opportunities

  • Rise in the use of point of care diagnostic products
  • Increase in demand for lab automation
  • Surge in the prevalence of lifestyle diseases

Diagnostic Tests Market Dynamics

This section deals with understanding the market drivers, opportunities, restraints and challenges. All of this is discussed in detail as below:

Drivers

  • Use of Point Of Care Diagnostic Products

The rise in the use of point of care diagnostic products introducing decentralization trend in the healthcare industry acts as one of the major factors driving the growth of diagnostic tests market as they are more prone to chronic diseases.

  • Disease Management

The increase in demand for lab automation and development of sophisticated and specialized tests for early disease detection and disease management accelerate the market growth.

  • Lifestyle Diseases

The surge in the prevalence of lifestyle diseases, such as atherosclerosis, heart disease, and stroke further influence the market.

Opportunities

Furthermore, increase in the healthcare decentralization extend profitable opportunities to the market players in the forecast period of 2022 to 2029. Also, surge in investments and funding for product development will further expand the market.

Restraints/Challenges Global Diagnostic Tests Market

On the other hand, pricing pressure owing to reimbursement cuts and budget constraints and stringent regulatory policies are expected to obstruct market growth. Also, lack of alignment with definitive central lab methods and inadequate adoption of POC devices in professional settings are projected to challenge the diagnostic tests market in the forecast period of 2022-2029.

This diagnostic tests market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on diagnostic tests market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Covid-19 Impact on Diagnostic Tests Market

COVID-19 had a negative impact on the diagnostic tests market owing to the supply chain disruptions and COVID-19 restrictions imposed by government. The manufacturing sector was hardly hit by the pandemic that declined the growth of the market. The implementation of global lockdown impacted the production schedules of the manufacturing industries. The sales dropped down amid the lockdown that resulted in drop in sales ratio and limited deliveries. However, market will resume its growth in the post-pandemic due to the easing in restrictions that were imposed earlier.

Recent Developments

  • Roche launched its Cobas Pulse System in selected countries accepting the CE Mark in January’2021. The product is Roche Diagnostics’ newest generation of connected point-of-care solutions. The new launch offers professional blood glucose management.

Global Diagnostic Tests Market Scope and Market Size

The diagnostic tests market is segmented on the basis of type, solution, technology, mode of testing, approach, sample type, application, testing type, age, end user and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Glucose Test
  • Infectious Diseases Test
  • Cytology Test
  • CBC Test
  • Blood Culture Test
  • Syphilis Test
  • Urea Test
  • C-Reactive Protein Test
  • Antigen Test
  • HBA1C Test
  • Pregnancy Test
  • Lipid Profile Test
  • Electrolytes Test
  • Liver Function Test
  • Stool Helicobacter Pylori Test
  • Calcium Test, Crossmatch Test
  • Thyroid Function Test
  • Stool Microscopy Test
  • Urine Microscopy Test
  • Unit Packed Rbcs Test
  • ESR Test And Others Test

On the basis of type, the diagnostic tests market is classified into glucose test, infectious diseases test, cytology test, CBC test, blood culture test, syphilis test, urea test, C-reactive protein test, antigen test, HBA1C test, pregnancy test, lipid profile test, electrolytes test, liver function test, stool helicobacter pylori test, calcium test, crossmatch test, thyroid function test, stool microscopy test, urine microscopy test, unit packed RBCs test, ESR test and others test. 

Solutions

  • Services
  • Products

On the basis of solution, the diagnostic tests market is segmented into services and products.

Technology

  • Immunoassay-Based
  • PCR-Based
  • Next Gene Sequencing
  • Spectroscopy-Based
  • Chromatography-Based
  • Microfluidics
  • Substrate Technology
  • Others

On the basis of technology, the diagnostic tests market is segmented into immunoassay-based, PCR-based, next gene sequencing, spectroscopy-based, chromatography-based, microfluidics, substrate technology and others.

Mode of Testing

  • Prescription-Based Testing
  • OTC Testing

On the basis of mode of testing, the diagnostic tests market is segmented into prescription-based testing and OTC testing. Prescription-based testing segment is expected to dominate the market as majority of the diagnostics test are prescription-based in order to help in the detection, treatment and control of the disease.  

Approach

  • Molecular Diagnostic Instrument
  • In-Vitro Diagnostic Instrument
  • Point Of Care Testing Instrument

On the basis of approach, the diagnostic tests market is segmented into molecular diagnostic instrument, in-vitro diagnostic instrument and point of care testing instrument. In-vitro diagnostic Instrument segment is expected to dominate the market as in-vitro diagnostic preference is continuously increasing to analyze samples such as blood and saliva to detect diseases or other conditions. Further, in-vitro diagnostic instrument is expected to increase in the forecast period with continuous increase in geriatric population and the subsequent growth in the prevalence of infectious and chronic diseases.

Sample Type

  • Urine
  • Saliva
  • Blood
  • Hair
  • Sweat
  • Others

On the basis of sample type, the diagnostic tests market is segmented into urine, saliva, blood, hair, sweat and others. Blood segment is expected to dominate the market as majority of the diagnosis test are prescription-based in which blood test is majorly prescribed in order to detect, treat and control disease.   

Application

  • Cardiology
  • Oncology
  • Neurology
  • Orthopedics
  • Gastroenterology
  • Gynecology
  • Odontology
  • Others

On the basis of application, the diagnostic tests market is segmented into cardiology, oncology, neurology, orthopedics, gastroenterology, gynecology, odontology and others. Cardiology segment is expected to dominate the market due continuous increase in number heart patients and other cardiovascular diseases around the world. Majority of the cardiovascular diseases require diagnosis test for detection and treatment of cardiovascular diseases. 

Testing Type

  • Biochemistry
  • Hematology
  • Microbiology
  • Histopathology
  • Others

On the basis of testing type, the diagnostic tests market is segmented into biochemistry, hematology, microbiology, histopathology and others. Hematology segment is expected to dominate the market as mostly diagnosis test are performed by using Blood for detection and identification of diseases.

Age

  • Pediatric
  • Adult
  • Geriatric

On the basis of age market is segmented into pediatric, adult and geriatric. Geriatric segment is expected to dominate the market as majority of diagnosis tests are performed on geriatric patients. Geriatric patients require regular monitoring/diagnosis as geriatric patients are more prone to infectious, chronic diseases and non-chronic diseases.   

End User

  • Hospitals, Diagnostic Center
  • Research Labs and Institutes
  • Research Institute
  • Homecare
  • Blood Banks
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Others

On the basis of end user, the diagnostic tests market is segmented into hospitals, diagnostic center, research labs & institutes, research institute, homecare, blood banks, specialty clinics, ambulatory surgical centers and others. Hospitals segment is expected to dominate the market as hospitals are performing various diagnostic tests such as glucose test, infectious diseases test, cytology test, CBC test, blood culture test, syphilis test, urea test, C-reactive protein test, antigen test, HBA1C test, causing for detection and treatment of serious disease or other major conditions.  

Distribution Channel

  • Direct Tenders
  • Retail Sales
  • Online Sales

On the basis of distribution channel, the diagnostic tests market is segmented into direct tenders, retail sales and online sales. Direct tenders segment is expected to dominate the market as most of the industrial user, clinical laboratories, academic and research institutes, diagnostic centers prefer direct tenders for seeking the benefits of bulk buying, discounts and easy availability of products.  

Diagnostic Tests Market Regional Analysis/Insights

The diagnostic tests market is analysed and market size insights and trends are provided by country, type, solution, technology, mode of testing, approach, sample type, application, testing type, age, end user and distribution channel as referenced above.

The countries covered in the diagnostic tests market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the diagnostic tests market because of the rise in the geriatric population base within the region.

Asia-Pacific (APAC) is expected to witness significant growth during the forecast period of 2022 to 2029 due to the availability of cost-effective diagnostic tests related to chronic diseases in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The diagnostic tests market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for diagnostic tests market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the diagnostic tests market. The data is available for historic period 2010-2020.

Competitive Landscape and Diagnostic Tests Market Share Analysis

The diagnostic tests market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to diagnostic tests market.

Some of the major players operating in the diagnostic tests market are:

  • F-Hoffman La-Rcohe Ltd. (Switzerland)
  • ABBOTT (US)
  • Danaher (US)
  • BD (US)
  • Thermo Fisher Scientific Inc. (US)
  • ACON Laboratories Inc. (US)
  • Hemosure, Inc. (US)
  • MicroGen Diagnostics (US)
  • QIAGEN (Germany)
  • Grifols, S.A (Spain)
  • BODITECH MED INC. (South Korea)
  • Chembio Diagnostic Systems, Inc. (US)
  • Nanoentek (South Korea)
  • DiaSorin S.p.A. (Italy)
  • Bio-Rad Laboratories, Inc. (US)
  • BIOMEDOMICS INC (US)
  • EKF Diagnostics Holdings plc (UK)
  • Siemens Healthcare GmbH (Germany)
  • PerkinElmer Inc. (US)
  • bioMérieux SA (France)
  • ARKRAY USA, Inc. (US)
  • Biohit Oyj (Finland)
  • Germaine Laboratories, Inc. (US)
  • Quidel Corporation (US)
  • Illumina, Inc. (US)
  • Lamdagen Corporation (US)
  • LifeSign LLC. (US)
  • Medixbiochemica (Finaland)
  • Nova Biomedical (US)
  • Ortho Clinical Diagnostics (US)
  • Sannuo Biosensing Co., Ltd. (US)
  • STRECK (US)
  • Sysmex Corporation (Japan)

Research Methodology : Global Diagnostic Tests Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-diagnostic-tests-market

Customization Available : Global Diagnostic Tests Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions

The Diagnostic Tests Market will be projected at USD 339,892.97 million during the forecast by 2029.
The Diagnostic Tests Market is Expected to Witness CAGR of 9.00% During the Forecast Period of 2022 to 2029.
The Major Players Operating in the Diagnostic Tests Market are H-Hoffman La-Rcohe Ltd. (Switzerland), ABBOTT (US), Danaher (US), BD (US), Thermo Fisher Scientific Inc. (US), ACON Laboratories Inc. (US), Hemosure, Inc. (US), MicroGen Diagnostics (US), QIAGEN (Germany), Grifols, S.A (Spain), BODITECH MED INC. (South Korea), among others.
The Countries Covered in the Diagnostic Tests Market Report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
The Diagnostic Tests Market Report Curated by the Data Bridge Market Research Team Includes In-Depth Expert Analysis, Patient Epidemiology, Pipeline Analysis, Pricing Analysis, and Regulatory Framework.